MEDICAL RESOURCES

M9241 (NHS-IL12) (IL-12 cancer immunotherapy)

Status

• M9241 is an investigational cancer immuno-cytokine designed for targeted delivery of IL-12 to the tumor microenvironment by targeting regions of tumor necrosis and apoptosis using a naked DNA-detecting antibody

Action SVG
Action SVG
Action SVG
eMedI Chat
Close
After your vist, Please answer a few questions to help us improve?
Survey
Please click on icon to provide survey...